BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cui XR, Guo YH, Liu QQ. Cangma Huadu granules, a new drug with great potential to treat coronavirus and influenza infections, exert its efficacy through anti-inflammatory and immune regulation. J Ethnopharmacol 2022;287:114965. [PMID: 34990767 DOI: 10.1016/j.jep.2021.114965] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu M, Liu T, Wang X, Yu C, Qin T, Li J, Zhang M, Li Z, Cui X, Xu X, Liu Q. Cangma Huadu granules attenuate H1N1 virus-induced severe lung injury correlated with repressed apoptosis and altered gut microbiome. Front Microbiol 2022;13:947112. [DOI: 10.3389/fmicb.2022.947112] [Reference Citation Analysis]
2 Cui H, Zhang C, Zhang C, Cai Z, Chen L, Chen Z, Zhao K, Qiao S, Wang Y, Meng L, Dong S, Liu J, Guo Z. Anti-Influenza Effect and Mechanisms of Lentinan in an ICR Mouse Model. Front Cell Infect Microbiol 2022;12:892864. [DOI: 10.3389/fcimb.2022.892864] [Reference Citation Analysis]
3 Gudowska-Sawczuk M, Mroczko B. The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review. Int J Mol Sci 2022;23:5283. [PMID: 35563673 DOI: 10.3390/ijms23095283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]